Reduced-dose nanoparticle albumin-bound-paclitaxel combined with ramucirumab as second-line treatment for advanced gastric cancer: a multicenter phase II study.
Iida M, Nakashima C, Kawaoka T, Kondo J, Yamamoto T, Yoshino S, Tokuno K, Kuga T, Dairaku K, Nakagami Y, Watanabe Y, Matsui H, Shindo Y, Takahashi H, Ioka T, Nagano H
The online reader was unable to display this document directly. This may occur if the repository host is temporarily unreachable, or if security restrictions (CORS) prevent embedded viewing.